Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Brunet

Showing results (251-260 of 492) with videos related to

Pageof 50
Sort By:
Sangre|April 1, 1997
[Allogeneic transplant of CD34+ peripheral blood cells from HLA-identical donors: Spanish experience of 40 cases. Allo-Peripheral Blood Transplantation Group]A Urbano-Ispizua, C Solano, S Brunet, et al.
Bone Marrow Transplantation|January 9, 1998
Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phaseD Gallardo, J García-López, A Sureda, et al.
Leukemia|September 28, 2013
MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemiaM Díaz-Beyá, S Brunet, J Nomdedéu, et al.
Leukemia|May 27, 2006
Clinical outcome after sex-mismatched allogeneic stem cell transplantation from human lymphocyte antigen-identical sibling donors: influence of stem cell sourceD Gallardo, A Pérez-García, R de la Cámara, et al.
Haematologica|May 9, 1998
Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of HematologyJ M Ribera, J J Ortega, A Oriol, et al.
Haematologica|October 17, 2001
Severe infections after allogeneic peripheral blood stem cell transplantation: a matched-pair comparison of unmanipulated and CD34+ cell-selected transplantationR Martino, M Rovira, E Carreras, et al.
Bone Marrow Transplantation|April 2, 2013
A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCTB Martín-Antonio, M Suarez-Lledo, M Arroyes, et al.
Leukemia|May 7, 2015
Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registryT Bernal, P Martínez-Camblor, J Sánchez-García, et al.
Journal of the National Cancer Institute|July 21, 1999
Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancerE Warner, W Foulkes, P Goodwin, et al.
Transfusion|March 10, 2001
Donor age-related differences in PBPC mobilization with rHuG-CSFJ de La Rubia, M A Díaz, A Verdeguer, et al.
Pageof 50

Showing results (251-260 of 492) with videos related to

Sort By:
Pageof 50
Sangre|April 1, 1997
[Allogeneic transplant of CD34+ peripheral blood cells from HLA-identical donors: Spanish experience of 40 cases. Allo-Peripheral Blood Transplantation Group]A Urbano-Ispizua, C Solano, S Brunet, et al.
Bone Marrow Transplantation|January 9, 1998
Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phaseD Gallardo, J García-López, A Sureda, et al.
Leukemia|September 28, 2013
MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemiaM Díaz-Beyá, S Brunet, J Nomdedéu, et al.
Leukemia|May 27, 2006
Clinical outcome after sex-mismatched allogeneic stem cell transplantation from human lymphocyte antigen-identical sibling donors: influence of stem cell sourceD Gallardo, A Pérez-García, R de la Cámara, et al.
Haematologica|May 9, 1998
Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of HematologyJ M Ribera, J J Ortega, A Oriol, et al.
Haematologica|October 17, 2001
Severe infections after allogeneic peripheral blood stem cell transplantation: a matched-pair comparison of unmanipulated and CD34+ cell-selected transplantationR Martino, M Rovira, E Carreras, et al.
Bone Marrow Transplantation|April 2, 2013
A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCTB Martín-Antonio, M Suarez-Lledo, M Arroyes, et al.
Leukemia|May 7, 2015
Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registryT Bernal, P Martínez-Camblor, J Sánchez-García, et al.
Journal of the National Cancer Institute|July 21, 1999
Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancerE Warner, W Foulkes, P Goodwin, et al.
Transfusion|March 10, 2001
Donor age-related differences in PBPC mobilization with rHuG-CSFJ de La Rubia, M A Díaz, A Verdeguer, et al.
Pageof 50